About Ortho-McNeil Neurologics, Inc.
Ortho-McNeil Neurologics, Inc websiteOrtho-McNeil Neurologics emerged in April 2005 as a U.S. company focused on providing and advancing solutions that improve neurological health. The company currently markets products for Alzheimer's disease, epilepsy, and migraine prevention and treatment. Ortho-McNeil Neurologics continues to explore new opportunities to develop solutions for unmet health care needs in neurology in conjunction with internal and external partners.
Headquartered in Titusville, N.J. with more than 1,000 employees, the company draws on the rich neuroscience heritage of its two sister companies, Ortho-McNeil Pharmaceutical, Inc. and Janssen, L.P. Both of these companies hold innovation as a foremost approach to meeting customer needs, specifically through developing, producing and marketing, safe and differentiated products and services to improve health outcomes.
Ortho-McNeil Neurologics is uniquely positioned as strong and agile in its purpose to provide and advance solutions that improve neurological health. A focused, long-range view will foster deeper scientific understanding in the company's current therapeutic areas and facilitate development of solutions in new areas.
